Mylan NV Ord Shs(NASDAQ:MYL) stock News

MYL Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Bloomberg - Mentions: FB MRK MDT CRM ...

Biden Tax Plan Seen Hitting Tech, Pharmaceutical Companies

4 years ago - By: Bloomberg - Mentions: FB MRK MDT CRM ...

Biden Tax Plan Seen Hitting Technology, Pharmaceutical Companies

5 years ago - By: Bloomberg - Mentions: PFE BNTX MRNA

What to Know About Vaccine-Linked Deaths, Allergies

5 years ago - By: The Motley Fool - Mentions: PFE

3 Reasons Pfizer's Imminent Upjohn-Mylan Merger Is Great News for Investors

5 years ago - By: Bloomberg - Mentions: PFE BNTX MRNA

What to Know About Vaccine-Related Deaths, Allergies

5 years ago - By: CNBC - Mentions: AMZN AAPL FB ABBV ...

A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probe

5 years ago - By: Barron's - Mentions: PFE RJF MRNA BNTX ...

What We Know About How Moderna and Pfizer Vaccines Compare

5 years ago - By: Benzinga - Mentions: FHTX IVA DRNA ALKS ...

The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets

5 years ago - By: Zacks Investment Research - Mentions: PFE MRNA GSK BNTX

2 Stocks to Watch on Pfizer's 90% Effective COVID-19 Vaccine

5 years ago - By: The Motley Fool - Mentions: PFE BNTX

2 Best Pharma Stocks to Buy in November

5 years ago - By: Zacks Investment Research - Mentions: JNJ GSK TBPH

Theravance (TBPH) Drops on Q3 Earnings Miss, Revenues In Line

5 years ago - By: Zacks Investment Research - Mentions: PFE BIIB GSK

Mylan's (MYL) Q3 Earnings Surpass Estimates, Sales Miss

5 years ago - By: Zacks Investment Research

Mylan (MYL) Q3 Earnings Surpass Estimates

5 years ago - By: Mylan N.V.

Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.

5 years ago - By: Benzinga - Mentions: KURA PFE POAI SNDX ...

The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold

5 years ago - By: Zacks Investment Research - Mentions: GERN RGNX ENLV

What's in the Cards for Enlivex (ENLV) This Earnings Season?

5 years ago - By: Zacks Investment Research - Mentions: TLRY GERN RGNX

Is a Disappointment in Store for Tilray's (TLRY) Q3 Earnings?

5 years ago - By: Zacks Investment Research - Mentions: PFE GERN RGNX

Mylan (MYL) to Report Q3 Earnings: Is a Beat in the Cards?

5 years ago - By: Zacks Investment Research - Mentions: TEVA ACAD BNTX

TEVA Gears Up to Report Q3 Earnings: What's in the Cards?

5 years ago - By: Zacks Investment Research

Why Mylan (MYL) Might Surprise This Earnings Season

5 years ago - By: Mylan N.V.

Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris

5 years ago - By: Mylan N.V. - Mentions: PFE

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

5 years ago - By: Pfizer Inc. - Mentions: PFE

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

5 years ago - By: Zacks Investment Research

Will Mylan (MYL) Beat Estimates Again in Its Next Earnings Report?

5 years ago - By: Zacks Investment Research - Mentions: PFE BMY AMGN

Pfizer (PFE) Q3 Earnings Top, Sales Miss, View Narrowed

5 years ago - By: Zacks Investment Research - Mentions: BIIB JNJ

Mylan NV Ord Shs (MYL) Stock News

MYL Latest News, Press Relases and Analysis

Biden Tax Plan Seen Hitting Tech, Pharmaceutical Companies

Biden Tax Plan Seen Hitting Technology, Pharmaceutical Companies

What to Know About Vaccine-Linked Deaths, Allergies

3 Reasons Pfizer's Imminent Upjohn-Mylan Merger Is Great News for Investors

What to Know About Vaccine-Related Deaths, Allergies

A top Democrat on the House antitrust panel sets sights on Big Pharma after wrapping up tech probe

What We Know About How Moderna and Pfizer Vaccines Compare

The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets

2 Stocks to Watch on Pfizer's 90% Effective COVID-19 Vaccine

2 Best Pharma Stocks to Buy in November

Theravance (TBPH) Drops on Q3 Earnings Miss, Revenues In Line

Mylan's (MYL) Q3 Earnings Surpass Estimates, Sales Miss

Mylan (MYL) Q3 Earnings Surpass Estimates

Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.

The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold

What's in the Cards for Enlivex (ENLV) This Earnings Season?

Is a Disappointment in Store for Tilray's (TLRY) Q3 Earnings?

Mylan (MYL) to Report Q3 Earnings: Is a Beat in the Cards?

TEVA Gears Up to Report Q3 Earnings: What's in the Cards?

Why Mylan (MYL) Might Surprise This Earnings Season

Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn

Will Mylan (MYL) Beat Estimates Again in Its Next Earnings Report?

Pfizer (PFE) Q3 Earnings Top, Sales Miss, View Narrowed

Biogen (BIIB) Q3 Earnings Top, Tecfidera Generics Hurt Sales